Related Experiment Video
Updated: Jun 17, 2025
08:45
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
2.3K
The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression
Liushan Wei1, Shun Liu1, Zhizhong Xie1
1School of Pharmaceutical Science, Hengyang Medical College, University of South China, 28 Western Changsheng Road, Hengyang, Hunan 421001, People's Republic of China.
International Immunopharmacology
|August 8, 2024
Summary
m6A methylation and non-coding RNAs (ncRNAs) interact within the tumor microenvironment (TME) to influence cancer development. Understanding these interactions offers new therapeutic targets for various cancers.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer development is linked to epigenetic dysregulation, non-coding RNA (ncRNA) expression, and the tumor microenvironment (TME).
- N6-methyladenosine (m6A) methylation is a prevalent RNA modification impacting RNA fate and biological processes.
- m6A influences RNA processing, localization, degradation, and translation, affecting both messenger RNAs (mRNAs) and ncRNAs in cancer cells.
Purpose of the Study:
- To review the intricate interactions between m6A modifications and ncRNAs within the TME.
- To summarize the molecular mechanisms underlying m6A-ncRNA interactions in TME formation and cancer progression.
- To highlight the roles of these interactions in the development of diverse cancers and identify potential therapeutic targets.
Main Methods:
- Literature review focusing on m6A methylation, ncRNAs, and the TME.
- Analysis of molecular mechanisms governing m6A-ncRNA crosstalk.
- Synthesis of current understanding of their roles in tumorigenesis.
Main Results:
- m6A methylation and ncRNAs are closely intertwined with TME formation.
- Complex regulatory networks arise from the interplay between m6A methylation and ncRNAs in the TME.
- These interactions mediate the progression of various cancers.
Conclusions:
- The interplay between m6A methylation and ncRNAs is crucial for TME modulation and cancer progression.
- Targeting m6A-ncRNA interactions within the TME presents a promising avenue for novel cancer therapies.
- Further research into these mechanisms will deepen our understanding of tumorigenesis.
Related Concept Videos
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
01:53RNA Stability
33.4K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.4K